Skip to content
العربية
BREAKING
News

ASUS MH Series Clinical Displays Listed as Class 1 Devices by FDA, TFDA, and EU MDR

ASUS MH Series Clinical Displays Listed as Class 1 Devices by FDA, TFDA, and EU MDR
Talal Abu-Ghazaleh Information Technology News (TAG-IT News)

Achieving FDA, TFDA and EU MDR listings, the ASUS MH series brings pinpoint DICOM-grade clarity and always-on calibration to every hospital workspace. 

• FDA, TFDA & EU MDR listings: MH3281A, MH2741A and MH2441A meet global medical-device standards
• Visual accuracy and consistency: DICOM Part 14 compliance, auto calibration and ensure accurate radiology/PACS visuals 

TAIPEI - ASUS  announced that the latest MH series clinical displays have been listed as Class 1 devices by the US Food and Drug Administration (FDA), the Taiwan Food and Drug Administration (TFDA), and the European Union Medical Device Regulation (EU MDR), a press release stated by ASUS.

ASUS MH series clinical displays include the 32-inch / 8-megapixel MH3281A, the 27-inch / 4-megapixel MH2741A, and the 23.8-inch MH2441A. All are designed for radiology as well as Picture Archiving and Communication System (PACS) use. Each monitor meets the DICOM Part 14 Grayscale Standard Display Function (GSDF) AAPM TG270 standard, and each includes a scheduled calibration feature, dynamic brightness compensation, and dynamic DICOM compensation to ensure consistent and highly accurate medical images. In addition, each monitor features an anti-glare, low-reflection (AGLR) coating on the panel, and each has been certified by TÜV Rheinland to ensure flicker-free performance and low blue light emissions. These clinical displays also meet ISO 13485 requirements. 
 

Related News

TAG-IT News Briefing

Top technology headlines, delivered to your inbox

You can unsubscribe at any time via the link at the bottom of every email.
Accessibility Tools login